Article
Impaired CD4+ cell recovery during antiretroviral therapy in patients with HIV resistance mutations.
Archives of virology - 1 Mar 2012
Sühs Kurt-Wolfram, Stoll M, Diem R, Schmidt R E, Heiken H
Abstract excerpt
Antiretroviral therapy is limited by the development of human immunodeficiency virus (HIV) resistance mutations. Although resistance testing is recommended during therapy failure, little is known about the optimal time points for testing or its impact on treatment. In this study, we investigated HIV polymorphisms and mutations and assessed their influence on the outcome of highly active antiretroviral therapy...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
